Amneal Pharmaceuticals (AMRX) Assets Average (2018 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Assets Average of $3.6 billion for Q1 2026, up 5.12% year-over-year from $3.4 billion in Q1 2025, and down 0.82% quarter-over-quarter from $3.6 billion in Q4 2025.
Amneal Pharmaceuticals (AMRX) Assets Average (2018 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Assets Average history runs 9 years deep, the most recent figure standing at $3.6 billion for Q1 2026.
- In Q1 2026, Assets Average rose 5.12% year-over-year to $3.6 billion; the TTM figure through Mar 2026 stood at $3.6 billion (up 5.12% YoY), while the FY2025 annual figure was $3.6 billion, up 2.95% from the prior year.
- Assets Average for Q1 2026 stood at $3.6 billion, down from $3.6 billion in the prior quarter.
- The five-year high for Assets Average was $4.0 billion in Q2 2022, with the low at $3.4 billion in Q2 2025.
- The 5-year median for Assets Average is $3.6 billion (2026), against an average of $3.6 billion.
- The sharpest annual moves came in 2023 and 2026: Assets Average dropped 7.6% in 2023, then gained 5.12% in 2026.
- Amneal Pharmaceuticals' Assets Average stood at $3.8 billion in 2022, then decreased by 6.69% to $3.6 billion in 2023, then declined by 2.75% to $3.5 billion in 2024, then increased by 4.53% to $3.6 billion in 2025, then slipped by 0.82% to $3.6 billion in 2026.
- Business Quant data shows AMRX's Assets Average at $3.6 billion in Q1 2026, $3.6 billion in Q4 2025, and $3.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 3.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.66 Bn |
| Mar 31, 2026 | 3.61 Bn |
| Dec 31, 2025 | 3.64 Bn |
| Sep 30, 2025 | 3.51 Bn |
| Jun 30, 2025 | 3.39 Bn |
| Mar 31, 2025 | 3.43 Bn |
| Dec 31, 2024 | 3.48 Bn |
| Sep 30, 2024 | 3.49 Bn |
| Jun 30, 2024 | 3.48 Bn |
| Mar 31, 2024 | 3.46 Bn |
| Dec 31, 2023 | 3.58 Bn |
| Sep 30, 2023 | 3.69 Bn |
| Jun 30, 2023 | 3.66 Bn |
| Mar 31, 2023 | 3.71 Bn |
| Dec 31, 2022 | 3.84 Bn |
| Sep 30, 2022 | 3.96 Bn |
| Jun 30, 2022 | 3.97 Bn |
| Mar 31, 2022 | 3.91 Bn |
| Dec 31, 2021 | 3.96 Bn |
| Sep 30, 2021 | 4.00 Bn |